Nur Nicholson
CIK 1827317 · Chief Technical Officer · last filed 2026-05-14
Nur Nicholson is a Chief Technical Officer who has filed 22 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
22
-$2.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Technical Officer | 24,284 | $41.03 | $996.4K | -$2.45M | 22 | 2026-05-14 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −204,277 | $0 | EDGAR |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +45,220 | $0 | EDGAR |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −7,725 | -$168.1K | EDGAR |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,203 | -$43.6K | EDGAR |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,618 | -$58.1K | EDGAR |
| 2025-06-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −825 | -$24.4K | EDGAR |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −3,948 | -$120.1K | EDGAR |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +34,281 | -$64.3K | EDGAR |
| 2025-01-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,632 | -$75.5K | EDGAR |